Ideaya Biosciences Stock Investor Sentiment

IDYA Stock  USD 26.54  0.25  0.93%   
About 66% of Ideaya Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Ideaya Biosciences suggests that many traders are alarmed. The current market sentiment, together with Ideaya Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Ideaya Biosciences stock news signals to limit their universe of possible portfolio assets.

Panic Vs Confidence

34

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Ideaya Biosciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Ideaya Biosciences.

Ideaya Historical Sentiment

Although Ideaya Biosciences' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Ideaya, such as negative comments on social media and news outlets, may cause fear in the market and push Ideaya Biosciences' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Ideaya.
  

Ideaya Biosciences Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Ideaya Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Ideaya Biosciences Historical Investor Sentiment

Investor biases related to Ideaya Biosciences' public news can be used to forecast risks associated with an investment in Ideaya. The trend in average sentiment can be used to explain how an investor holding Ideaya can time the market purely based on public headlines and social activities around Ideaya Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ideaya Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ideaya Biosciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Ideaya Biosciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Ideaya Biosciences.
over three months ago at benzinga.com         
IDEAYA Biosciences Highlights Encouraging Preliminary Efficacy, Safety Profile For Patients With Har...
benzinga news
over three months ago at seekingalpha.com         
Mizuho starts Ideaya at outperform, cites partnerships, cash runway
seekingalpha News
over three months ago at news.google.com         
IDEAYA Biosciences, Inc. Stock Holdings Increased by Principal Financial Group Inc. - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
IDEAYA Announces Investor Webcast to Report Clinical Data Update for IDE397 Phase 2 Monotherapy Expa...
Google News at Macroaxis
over three months ago at simplywall.st         
Even though IDEAYA Biosciences has lost US182m market cap in last 7 days, shareholders are still up ...
Simply Wall St News at Macroaxis
over three months ago at news.google.com         
On The My Stocks Page - Stock Traders Daily
Google News at Macroaxis
over three months ago at news.google.com         
IDEAYA Biosciences Trying To Close In On Key Technical Measure - Investors Business Daily
Google News at Macroaxis
over three months ago at finance.yahoo.com         
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635
Yahoo News
over three months ago at www.macroaxis.com         
Disposition of 47060 shares by Throne Jason of Ideaya Biosciences at 7.01 subject to Rule 16b-3
Macroaxis News
over three months ago at www.macroaxis.com         
Disposition of 627 shares by Yujiro Hata of Ideaya Biosciences at 4.31 subject to Rule 16b-3
Macroaxis News
over three months ago at finance.yahoo.com         
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE397 and Trode...
Yahoo News
over three months ago at finance.yahoo.com         
IDEAYA Biosciences Announces Clinical Program Updates for IDE397 a Potential First-in-Class Phase 2 ...
Yahoo News
over three months ago at news.google.com         
IDEAYA Biosciences, Inc. Receives Consensus Rating of Buy from Brokerages - Defense World
Google News at Macroaxis
over three months ago at finance.yahoo.com         
Investors in IDEAYA Biosciences have seen impressive returns of 277 percent over the past five years
Yahoo News
over three months ago at news.google.com         
IDEAYA Biosciences Shares Gap Up to 37.58 - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ideaya Biosciences that are available to investors today. That information is available publicly through Ideaya media outlets and privately through word of mouth or via Ideaya internal channels. However, regardless of the origin, that massive amount of Ideaya data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ideaya Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ideaya Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ideaya Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ideaya Biosciences alpha.

Ideaya Biosciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Citi gives its top picks for clients heading into the fourth quarter
10/03/2024
2
IDEAYA Biosciences, Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update
11/04/2024
3
IDEAYA Biosciences Posts Earnings Results, Beats Expectations By 0.03 EPS
11/07/2024
4
Biocytogen Announces IDEAYAs Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3PTK7 Topo-I-Payload Bispecific ADC and Option Exercise
11/11/2024
5
IDEAYAB7H3PTK7ADC
11/13/2024
6
Jim Cramer Says This Tobacco Stock Is Undervalued But Hes Not Recommending It
11/15/2024
7
IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer
11/18/2024

Complementary Tools for Ideaya Stock analysis

When running Ideaya Biosciences' price analysis, check to measure Ideaya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ideaya Biosciences is operating at the current time. Most of Ideaya Biosciences' value examination focuses on studying past and present price action to predict the probability of Ideaya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ideaya Biosciences' price. Additionally, you may evaluate how the addition of Ideaya Biosciences to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
CEOs Directory
Screen CEOs from public companies around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Commodity Directory
Find actively traded commodities issued by global exchanges